LifeMD, Inc. (LFMD) Financial Statements
Industry: Offices & Clinics of Doctors of Medicine (Services)
In fiscal 2025, LifeMD reported revenue of $194.1M, down 8.7% from $212.5M the year before. Net income was $14.4M (a 7.4% net margin), or $0.25 per diluted share. Gross margin was 85.7% and operating margin was -4.0%. Operating activities generated $8.3M of cash, leaving $6.4M of free cash flow. At fiscal year end, LifeMD held $70.4M in total assets against $47.3M in total liabilities.
Open the full interactive LifeMD financials → Quarterly statements, key ratios, valuation history and price charts.
LifeMD Key Stats
| Share Price | $2.47 |
|---|---|
| Market Cap | $118.0M |
| P/E Ratio | 9.9 |
| Dividend Yield | 2.63% |
| Revenue YoY Growth | -8.7% |
| 52-Week Range | $2.47 – $6.43 |
| Shares Outstanding | 47.8 million (basic, 2026 Q2) |
LifeMD Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $37.3M | $92.9M | $119.0M | $152.5M | $212.5M | $194.1M |
| Gross Profit | $28.4M | $74.9M | $100.4M | $133.6M | $188.4M | $166.3M |
| Operating Income | -$57.8M | -$54.3M | -$43.4M | -$14.5M | -$16.1M | -$7.7M |
| Pre-Tax Income | -$60.4M | -$61.3M | -$44.7M | -$17.4M | -$18.3M | -$10.2M |
| Income Tax | $122,500 | $7,700 | $360,700 | $428,000 | $402,000 | $45,721 |
| Net Income | -$58.6M | -$60.9M | -$45.5M | -$20.6M | -$18.9M | $14.4M |
| Diluted EPS | -$4.11 | -$2.25 | -$1.47 | -$0.61 | -$0.46 | $0.25 |
LifeMD Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $60.2M | $6.0M | $50.2M | $47.3M |
| Net Income | -$3.8M | $18.9M | -$8.9M | -$7.1M |
| Diluted EPS | -$0.08 | $0.42 | -$0.20 | -$0.16 |
LifeMD Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.2M | $41.3M | $4.0M | $33.1M | $35.0M | — |
| Current Assets | $12.1M | $44.9M | $11.3M | $42.6M | $48.7M | $51.8M |
| Total Assets | $13.1M | $49.9M | $25.7M | $58.5M | $72.5M | $70.4M |
| Current Liabilities | $13.5M | $22.8M | $31.4M | $34.8M | $60.3M | $41.6M |
| Total Long-Term Debt | — | — | — | — | $18.3M | — |
| Total Liabilities | $13.9M | $24.1M | $33.0M | $52.9M | $76.5M | $47.3M |
| Shareholders' Equity | -$2.3M | $22.7M | -$11.4M | $3.5M | -$5.5M | $23.2M |
LifeMD Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$12.1M | -$33.1M | -$22.9M | $8.8M | $17.5M | $8.3M |
| Cash From Investing | -$798,136 | -$3.4M | -$13.9M | -$8.7M | -$11.5M | $6.9M |
| Cash From Financing | $21.0M | $68.6M | -$528,200 | $29.1M | -$4.1M | -$13.4M |
| Free Cash Flow | — | -$33.3M | -$23.3M | $8.6M | $16.0M | $6.4M |
| Dividends Paid | — | $871,476 | $3.1M | $3.1M | $3.1M | $3.1M |
Figures from LifeMD's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full LifeMD financials page for every line item.
LifeMD Company Profile
| Ticker | LFMD |
|---|---|
| Exchange | Nasdaq |
| Industry | Offices & Clinics of Doctors of Medicine (Services) |
| Headquarters | New York, New York |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0000948320 |
Frequently Asked Questions
What was LifeMD's revenue in fiscal 2025?
LifeMD (LFMD) reported revenue of $194.1M for fiscal 2025.
What is LifeMD's annual revenue history?
LifeMD's annual revenue by fiscal year: 2020: $37.3M; 2021: $92.9M; 2022: $119.0M; 2023: $152.5M; 2024: $212.5M; 2025: $194.1M.
What was LifeMD's net income in fiscal 2025?
LifeMD reported net income of $14.4M for fiscal 2025.
What was LifeMD's earnings per share (EPS) in fiscal 2025?
LifeMD's diluted EPS was $0.25 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did LifeMD generate in fiscal 2025?
LifeMD generated $6.4M of free cash flow in fiscal 2025.
What was LifeMD's revenue last quarter?
In its most recent reported quarter (2026 Q2), LifeMD reported revenue of $47.3M.
How many shares of LifeMD are outstanding?
LifeMD reported a weighted average of 47.8 million basic shares outstanding in 2026 Q2.
What is LifeMD's market cap?
Based on its latest closing price, LifeMD (LFMD) has a market capitalization of about $118.0M.
When does LifeMD's fiscal year end?
LifeMD's fiscal year end, as registered with the SEC, is December 31.
Where is LifeMD headquartered?
LifeMD lists its business address in New York, New York in its SEC filings.